Work

Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed AML or High-Risk MDS

Year: 2015

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.07.027

Authors: Anna B. Halpern, Asma Anwar, Bart L. Scott, Pamela S. Becker, Megan Othus, Paul C. Hendrie, Elizabeth M. Ranker, Andrea Perdue, Heather A. Smith, Tara L. Chen, Sarah A. Buckley, Kaysey F. Orlowski, Morgan A. Powell, Elihu H. Estey, Roland B. Walter

Institutions: University of Washington, Fred Hutch Cancer Center, Seattle Cancer Care Alliance

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2221153767

FWCI:

Cites:

Cited by:

Related to: 10